Medical Properties Trust, Inc. (MPT)
NYSE: MPT · Real-Time Price · USD
3.500
-0.070 (-1.96%)
At close: Sep 28, 2026, 4:00 PM EDT
3.500
0.00 (0.00%)
Pre-market: Sep 29, 2026, 4:10 AM EDT
Medical Properties Trust Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Medical Properties Trust stock has a consensus rating of "Hold" and an average price target of $5.13. The average 1-year stock price forecast is 46.57% higher than the current stock price, while the lowest is $4.25 (+21.43%) and the highest is $7.00 (+100.00%).
Price Target: $5.13 (+46.57%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Medical Properties Trust stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Sep 18, 2026 |
| KeyBanc | KeyBanc | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 17, 2026 |
| Wells Fargo | Wells Fargo | Sell Reiterates $5 → $3.8 | Sell | Reiterates | $5 → $3.8 | +8.57% | Sep 1, 2026 |
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Sell Reiterates $5 → $4.25 | Sell | Reiterates | $5 → $4.25 | +21.43% | Aug 17, 2026 |
| Colliers Securities | Colliers Securities | Buy Maintains $6.5 → $5 | Buy | Maintains | $6.5 → $5 | +42.86% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
1.04B
from 1.07B
Decreased by -3.00%
Revenue Next Year
1.08B
from 1.04B
Increased by 3.86%
EPS This Year
0.11
EPS Next Year
0.05
from 0.11
Decreased by -54.55%
EPS based on non-GAAP adjusted numbers.